Cargando…

Children’s SARS-CoV-2 Infection and Their Vaccination

SARS-CoV-2, a novel coronavirus, causes respiratory tract infections and other complications in affected individuals, and has resulted in numerous deaths worldwide. The unprecedented pace of its transmission worldwide, and the resultant heavy burden on healthcare systems everywhere, prompted efforts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Sneh Lata, Tyagi, Rohit, Dhar, Atika, Oswal, Neelam, Khandelwal, Ankita, Jaiswal, Rishi Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962844/ https://www.ncbi.nlm.nih.gov/pubmed/36851295 http://dx.doi.org/10.3390/vaccines11020418

Ejemplares similares

Role of Immunoglobulin A in COVID-19 and Influenza Infections
por: Tyagi, Rohit, et al.
Publicado: (2023)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Neutralizing antibody: a savior in the Covid-19 disease
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

IgA Determines Bacterial Composition in the Gut
por: Gupta, Suman, et al.
Publicado: (2023)

An assessment of the strategy and status of COVID-19 vaccination in India
por: Gupta, Sneh Lata, et al.
Publicado: (2023)

Sex Differences in Cardiac Pathology of SARS-CoV2 Infected and Trypanosoma cruzi Co-infected Mice
por: Dhanyalayam, Dhanya, et al.
Publicado: (2022)

Immunotherapy: an alternative promising therapeutic approach against cancers
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection
por: Lata, Sneh, et al.
Publicado: (2022)

Infantile Immune Thrombocytopenic Purpura Secondary to Perinatal Transfer of SARS-CoV-2 Antibody
por: Oswal, Jitendra, et al.
Publicado: (2022)

Structural insights into SARS-CoV-2 proteins
por: Arya, Rimanshee, et al.
Publicado: (2021)

Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
por: Tyagi, Kritika, et al.
Publicado: (2023)

Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
por: Haider, Zahra, et al.
Publicado: (2021)

Integrated genomic view of SARS-CoV-2 in India
por: Kumar, Pramod, et al.
Publicado: (2020)

Comparative sequence analysis of SARS nCoV and SARS CoV genomes for variation in structural proteins
por: Sangwan, Jyoti, et al.
Publicado: (2022)

In-silico design of a potential inhibitor of SARS-CoV-2 S protein
por: Jaiswal, Grijesh, et al.
Publicado: (2020)

Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients
por: Prasad, Narayan, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation
por: Dhar, Atika, et al.
Publicado: (2019)

Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design
por: Jaiswal, Varun, et al.
Publicado: (2022)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 infection in children with chronic kidney disease
por: Krishnasamy, Sudarsan, et al.
Publicado: (2021)

Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
por: Chiok, Kim R., et al.
Publicado: (2023)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

Routine SARS‐CoV‐2 vaccination for all children
por: De Paris, Kristina, et al.
Publicado: (2022)

SARS-CoV-2 infection in children and implications for vaccination
por: Nathanielsz, Jordan, et al.
Publicado: (2022)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
por: Sohpal, Vipan Kumar
Publicado: (2020)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ik6s8d7b87r0v87il8lagakb6j